Cheryl Guttman Krader
Cheryl Guttman Krader is a contributor to Dermatology Times, Ophthalmology Times, and Urology Times.
Prostate Ca test accurately predicts high-grade disease
Results from the U.S. validation study of a test that combines plasma levels of four prostate-specific kallikreins with clinical data demonstrated it accurately predicts high-grade prostate cancer and is superior to a validated clinical variable-based risk calculator.
New biomarkers address key aspects of prostate Ca management
New biomarkers for prostate cancer are showing great promise for addressing the limitations of existing diagnostic and prognostic tools, according to opinion leaders who spoke on this topic at the Large Urology Group Practice Association annual meeting in Chicago.
MRI-targeted prostate biopsy offers four fundamental benefits
Magnetic resonance imaging (MRI) is a promising tool for optimizing prostate cancer biopsy that appears to overcome the shortcomings of conventional systematic transrectal ultrasound (TRUS)-guided biopsy and also provides novel information for risk stratification that can guide the decision of whether to perform biopsy, according to Samir Taneja, MD.
Ocriplasmin for VMA: Lessons learned
Analyses of data from patients treated for vitreomacular adhesion at a single center provide insights for management decisions and patient counseling.
Unsupervised machine learning identifies patterns of glaucoma-related binocular visual field loss
Glaucoma researchers developing machine-learning techniques to identify patterns of glaucoma-related visual field loss, without human supervision, and to detect progression of glaucoma based on these patterns are reporting their experience in applying their methods to binocular visual fields.
Role of steroids in bacterial keratitis further defined
The Steroids for Corneal Ulcers Trial allays some fears about using a topical corticosteroid as an adjunct to antibiotic treatment in eyes with a bacterial corneal ulcer.
Ocriplasmin outcomes favorable in post-marketing experience
Data reported by American surgeons using ocriplasmin for treatment of symptomatic vitreomacular adhesion (VMA) show that it is possible to increase the success rate through careful patient selection, said David Chow, MD.
Timing is everything when managing misaligned toric IOLs
When misalignment of a toric IOL underlies a suboptimal outcome and the problem is identified during early postoperative follow-up, surgeons should not procrastinate about taking the patient back to the operating room for a repositioning procedure, said Roger F. Steinert, MD.
RARP: ‘Little clear benefit’ compared to open surgery
Robot-assisted radical prostatectomy is associated with a lower rate of blood transfusion and shorter length of stay compared to open surgery. However, the total first-year reimbursement is higher for RARP and there is no difference between the two procedures in the rate of postoperative complications or use of additional cancer treatment, according to an analysis of contemporary data from the Surveillance, Epidemiology, and End Results Medicare-linked database.
Vitreoretinal surgeon gives thumbs up to heads-up surgery
There are already several good reasons for ophthalmic surgeons to perform “heads-up” surgery. Further benefits to support its use are anticipated as the technology continues to evolve, said Claus Eckardt, MD, professor of ophthalmology, Klinikum Frankfurt Höchst, Frankfurt, Germany.